信宇人(688573) - 2024 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2024 was ¥52,838,542.99, representing a decrease of 24.35% compared to the same period last year[2]. - The net profit attributable to shareholders was -¥28,507,969.28, with a basic and diluted earnings per share of -¥0.29[2]. - The net profit for Q1 2024 was -28,923,012.44 RMB, compared to -17,925,092.40 RMB in Q1 2023, representing an increase in net loss of approximately 61.5% year-over-year[17]. - Operating profit for Q1 2024 was -31,096,732.82 RMB, compared to -20,251,399.48 RMB in Q1 2023, indicating a deterioration of about 53.8% year-over-year[17]. - The total comprehensive income for Q1 2024 was -28,923,012.44 RMB, compared to -17,925,092.40 RMB in Q1 2023, showing a decline of approximately 61.5%[17]. Cash Flow and Liquidity - The net cash flow from operating activities was ¥91,386,278.55, primarily due to significant contract prepayments received during the quarter[5]. - Cash flow from operating activities generated a net inflow of 91,386,278.55 RMB in Q1 2024, a significant improvement from a net outflow of -39,007,221.40 RMB in Q1 2023[19]. - Total cash and cash equivalents at the end of Q1 2024 amounted to 335,273,596.24 RMB, up from 97,209,843.86 RMB at the end of Q1 2023, reflecting a year-over-year increase of approximately 245.5%[20]. - The company’s cash flow from financing activities resulted in a net outflow of -8,919,423.22 RMB in Q1 2024, contrasting with a net inflow of 23,822,754.02 RMB in Q1 2023[20]. - The company received 25,000,000.00 RMB in cash from borrowings in Q1 2024, compared to 6,443,581.80 RMB in Q1 2023, indicating an increase in financing activities[20]. Assets and Liabilities - Total assets at the end of the quarter were ¥1,959,272,496.72, reflecting a 5.92% increase from the end of the previous year[3]. - Current liabilities rose to CNY 944,527,976.40 in Q1 2024, compared to CNY 794,893,175.42 in Q1 2023, indicating increased short-term obligations[14]. - The company's total liabilities reached CNY 1,056,792,448.30 in Q1 2024, up from CNY 909,318,901.97 in Q1 2023, reflecting higher leverage[14]. - The equity attributable to shareholders decreased by 4.00% to ¥898,783,025.08 compared to the end of the previous year[3]. - The equity attributable to shareholders decreased to CNY 898,783,025.08 in Q1 2024 from CNY 936,273,165.38 in Q1 2023, indicating a decline in shareholder value[14]. Research and Development - Research and development expenses totaled ¥19,633,877.49, an increase of 55.48% year-over-year, accounting for 37.16% of total revenue[2][5]. - Research and development expenses increased to CNY 19,633,877.49 in Q1 2024, up from CNY 12,627,989.54 in Q1 2023, indicating a focus on innovation[16]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 5,131[6]. - Major shareholders include Yang Zhiming with 29.77% and Zeng Fang with 10.83% of the shares[7]. - The company has repurchased a total of 465,662 shares, accounting for 0.4764% of the total share capital, with a total expenditure of RMB 9,391,772.83[10]. - The company plans to use its own funds to repurchase shares totaling no less than RMB 20 million and no more than RMB 40 million, with a repurchase period of up to 12 months[9]. - The company’s board approved a share repurchase plan on February 19, 2024, aimed at employee stock ownership and incentive plans[9]. Other Financial Metrics - Non-recurring gains and losses amounted to ¥454,436.54, with a significant portion coming from the reversal of impairment provisions[4]. - The company reported a weighted average return on net assets of -3.10%, an increase of 1.86 percentage points year-over-year[2]. - The company reported a significant decrease in notes receivable, which fell to RMB 19,220,353.57 from RMB 59,490,693.19[12]. - Accounts receivable as of March 31, 2024, stood at RMB 441,712,979.62, slightly down from RMB 450,773,979.88 at the end of 2023[12]. - The company reported a net credit impairment loss of CNY -2,152,113.96 in Q1 2024, compared to a gain of CNY 4,370,951.58 in Q1 2023, highlighting changes in credit risk management[16]. Future Outlook - Future outlook includes a commitment to enhance product development and market expansion strategies, although specific targets were not detailed in the report[16]. - The company’s financial statements for the quarter ending March 31, 2024, are unaudited[11].